Error message

  • Strict warning: Only variables should be passed by reference in theme_biblio_tabular() (line 285 of /home/www/chspr/sites/all/modules/biblio/includes/
  • Strict warning: Only variables should be passed by reference in theme_biblio_tabular() (line 285 of /home/www/chspr/sites/all/modules/biblio/includes/

Canadian Rx Atlas, 3rd Edition


Related Publications

Smolina K, Weymann D, Morgan S, Ross C, Carleton B. Association between regulatory advisories and codeine prescribing to postpartum women. Journal of the American Medical Association. 2015;313(18):1861-2.
Suter E, Misfeldt R, Mallinson S, Wilhelm A, Boakye O, Marchildon G, et al. Comparative Review of the Policy Landscape of Team-based Primary Health Care Service Delivery in Western Canada. Alberta Health Services; 2014.
Laberge M, Pang J, Walker K, Wong ST, Hogg W, Wodchis WP. QUALICOPC (Quality and Costs of Primary Care) Canada: A focus on the aspects of primary care most highly rated by current patients of primary care practices. Ottawa, ON: Canadian Foundation for Healthcare Improvement; 2014.
McGregor MJ, Abu-Laban RB, Ronald L, McGrail KM, Andrusiek D, Baumbusch J, et al. Nursing Home Characteristics Associated with Resident Transfers to Emergency Department. Canadian Journal on Aging. 2012;33(1):38-48.

Publication Topics

Canadian Rx Atlas, 3rd Edition

Publication TypeAtlas
Year of Publication2013
AuthorsMorgan SG, Smolina K, Mooney D, Raymond C, Bowen M, Gorczynski C, Rutherford K
Date Published12/2013
PublisherCentre for Health Services and Policy Research
Citation Key658
Full Text

Canadians spent almost $23-billion on prescription drugs at retail pharmacies in 2012/13 – or over $650 per capita. That is a lot of money. However, after adjusting for general inflation, spending per capita actually fell over the past five years – despite the fact that the population was getting older.
This 3rd edition of The Canadian Rx Atlas breaks down retail spending on prescription drugs Canada, providing a detailed portrait of the factors driving spending trends over time and variations across provinces.
The Atlas gives a first-ever portrait of age- and sex-specific patterns of prescription drug use and costs across provinces. It also provides first-of-kind estimates of the source of financing for the prescriptions filled in every province.
Unique to the Canadian Rx Atlas, these details are not provided simply for all spending on prescription drugs; it also provides these details for each of 33 clinically and economically important therapeutic categories.
Download Full Atlas

Download Key Findings

Download by Section
To download a PDF copy of a specific section please click on the appropriate link below.

2. Cardiovascular system

3. Nervous system

4. Gastrointestinal tract and metabolism

5. Antineoplastic and immunomodulating agents

6. Respiratory system

7. Anti-infectives

8. Hormonal preparations

9. Musculo-skeletal system

10. Genito-urinary system

11. Sensory organs

Copyright: The excerpts from The Canadian Rx Atlas available from the links above are protected by copyright. They may be distributed for educational and non-commercial use, provided that the UBC Centre for Health Services and Policy Research is credited.